Series A · $50M · Africa-First · Evidence-Based

Africa's Cancer
Intelligence Infrastructure.

We are not building a health app. We are building the data infrastructure Africa's 1.4 billion people have never had — FDA-cleared devices, AI risk scoring, blockchain credentials, and mobile screening fleets in one platform.

$50M
Series A
77%
Gross Margin
1.4B+
Lives
Y2 Q2
EBITDA+
Africa expansion map
The Founding Story

An engineer turned
cancer fighter.

Our Founder & CEO is an engineer by profession. A cancer fighter by passion.

His aunt, Winnie, was a Senior State Registered Nurse with decades of service at Mpilo Hospital in Zimbabwe — a career built saving the lives of others.

A few weeks before she passed, one question was asked: "How could you not have seen this cancer coming — with all your years of experience?"

"I did not see it coming ... until it was too late."
— Winnie , Senior State Registered Nurse

Africa's cancer crisis is a data infrastructure problem. No population-level cancer dataset exists for sub-Saharan Africa. Without data, governments cannot plan. Insurers cannot price. Patients cannot be reached in time. Mandiera HealthTech is the engineering solution.

The Three Gaps

91% vs 60%
Breast cancer 5-year survival: USA vs Africa. The gap is not treatment — it is the stage at detection.
13,000
South African women die of cervical cancer each year — almost entirely preventable with early screening.
ZERO
Population-level cancer datasets for sub-Saharan Africa. Without data, there is no prevention.
The Platform

Three businesses. One data flywheel.

Every scan generates revenue. Every data point makes the platform more valuable. Every insurer relationship compounds the network.

🔬

OncoDetect™

FDA-cleared, non-invasive cancer screening devices. No radiation. No specialist. Results in 5 minutes.

iBreastExam™ CervAIcal™ OrCA™ RaKSA™
🧠

MedIntelligence™

Raw scan data transformed into the MCRI™ — Africa's first population cancer risk score. Licensed to insurers and governments at enterprise SaaS pricing.

MCRI™ Score
🏥

HealthPass™

Blockchain-signed certificate of verified cancer screening status. Verified by insurers via API. Africa's de facto cancer credentialing standard.

Blockchain-Verified
Full Platform Details →
Mobile Screening Fleet

Pink Pulse™ Fleet

Free screening, taken to the people who need it most.

Purpose-built mobile clinics staffed with a Registered Nurse, Nurse Assistant, and Driver/Security. Free to patients — funded by corporate CSR and government contracts.

💼
Track 1 — Insured: $24–$35/scan billed to medical aid. 77% gross margin.
💚
Track 2 — Community: FREE to patients. CSR & government funded. Data acquisition engine.
🚌
880–1,320
free community scans per unit / month

25
Target units
$7.5M
Fleet budget
Proof of Concept

Validated. Operational. Not theoretical.

🇮🇳

India Deployment

380,000+
scans · 22 govt hospitals · 86–88% accuracy

Same model we bring to Africa — nurse-operated, government-partnered, mobile-first.

🇿🇦

Vision World SA

✅ HPCSA-registered practitioners active
✅ Medical aid billing already live
✅ Multiple corporate clients served
✅ Health trend reports delivered
✅ Practitioner network operating

The fire is already burning.

📊

The Basepaws Precedent

Zoetis paid ~$93M for a cat DNA database — 37× revenue. The asset was the data.


Mandiera is building a human cancer intelligence database across 1.4 billion Africans. The acquirer buys infrastructure — not a screening company.

Full Proof of Concept →
Expansion Roadmap

From breast screening to genomics.
Phased. Deliberate. Scalable.

Phase 1

Breast Cancer

South Africa
iBreastExam™ · Insurer billing live · MCRI™ reports · Revenue begins
Phase 2

Cervical + Oral

SA + SADC
CervAIcal™ + OrCA™ · Pink Pulse™ fleet · Zimbabwe + Botswana
Phase 3

Multi-Cancer

SADC + East Africa
RaKSA™ · Enterprise SaaS · Pharma licensing · Kenya, Tanzania
Phase 4

Genomics

Full Continent
DNA from DBS cards · Africa genomics database · Cape to Cairo
Advisory Board

Named. Credentialed. Available for due diligence.

🔬

Medical Advisor

Neurology · WITS Medical School

Former Head of Neurology, WITS & CMJAH. Chair, PNNASA.

🩺

Clinical Oncology Advisor

Oncologist · Harare Oncology Centre

Clinical Oncologist. Founding Director, Harare Oncology Centre. Co-founder, CCNZ.

🧬

GI Malignancies Research

Gastroenterologist · University of Zimbabwe

MBBS, MMed, FCP(RSA). Africa cancer genetics specialist.

🎓

Training & Education Advisor

Vice Chancellor · WUA Zimbabwe

Clinical field staff training pipeline for Pink Pulse™ expansion.

Financial Snapshot

$5M → $131M in 5 years.

$131M
Year 5 Revenue
55%+
EBITDA Margin Y5
77%
Gross Margin/Scan
Y2 Q2
EBITDA Positive
Full Financial Model →
Exit Scenarios

Three paths to extraordinary returns.

JSE Main Board IPO

R2.8B ~$151M
Year 4–5 · 11–15× on $50M

Primary exit path. 25% public float. IPO advisory engaged.

Strategic Acquisition

$350M–$600M
Year 3–4 · Data Premium

Global pharma, NVIDIA, Google Health, or major insurer. Basepaws precedent: 37× revenue.

NASDAQ ADR

~$3.4B
Year 5–6 · Up to 68×

US listing via ADR. Health data SaaS multiples on NASDAQ.

Get In Touch

Ready to explore the opportunity?

We welcome introductions from institutional investors, family offices, impact investors, and strategic partners who share our vision for African health infrastructure.

📧
📧
General Enquiries
info@mandierahealth.tech
📞
WhatsApp Enabled
+27 76 655 1456 · +263 78 788 2665
📍
Head Office
Atrium on 5th, 5th Street, Sandton 2196, Johannesburg
Scan to Contact Us
QR code to contact
Scan with your phone camera

Request Investor Pack

Submit your details and we will send you the full Series A investor brief, financial model, and pitch deck.